30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Richard Giltner

Track

Insider profile

Currently holds a position at United Therapeutics Corp

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 74% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director United Therapeutics Corp April 29, 2009 -
Richard Giltner's trades of United Therapeutics Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-25 2025-06-24
S Sale
92,910 -19.8%
358.50
US$4,184,036 		92,910 -19.8% 358.50 US$4,184,036
2025-06-24 2025-06-24
PrS Proposed sale
31,061
335.61
US$3,210,114 		31,061 335.61 US$3,210,114
2024-11-06 2024-11-05
S Sale
11,228 -37.9%
446.33
US$3,021,223 		11,228 -37.9% 446.33 US$3,021,223
2024-11-06 2024-11-05
S Sale
8,571 -31.3%
381.61
US$3,270,749 		8,571 -31.3% 381.61 US$3,270,749
2024-11-05 2024-11-05
PrS Proposed sale
10,000
381.70
US$3,817,022 		10,000 381.70 US$3,817,022
2020-04-21 2020-04-20
PlS Planned sale
5,000 -57.1%
107.00
US$535,000 		5,000 -57.1% 107.00 US$535,000
2020-04-15 2020-04-14
PlS Planned sale
5,000 -57.1%
99.00
US$495,000 		5,000 -57.1% 99.00 US$495,000
2020-03-27 2020-03-26
S Sale
5,000 -57.1%
91.75
US$458,750 		5,000 -57.1% 91.75 US$458,750
2019-06-21 2019-06-20
PlS Planned sale
5,000 -100.0%
79.05
US$395,250 		5,000 -100.0% 79.05 US$395,250